67407-1-Ig

antibody from Proteintech Group

Targeting: KDR CD309, FLK1, VEGFR, VEGFR2

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

67407-1-Ig

Provider

Proteintech Group

Product name

VEGFR2 antibody

Antibody type

Monoclonal

Description

VEGFR2 antibody (Cat. #67407-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: FC, WB,ELISA.

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

1G2A8

Vial size

20ul, 150ul

References

Submitted references

Mechanistic insights into diclofenac-induced acute kidney injury and its antagonists identification.

Zhao F, Zhou X, Chen J, Li R, Sun Y, Zhou J, Li H, Zheng G, Zhu L
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2026 Feb;208:115889

---

Post-functionalized ZIF-8 for high-performance synergistic isolation of extracellular vesicles via co-precipitation.

Chen M, Xu F, Zhou S, Yu Y, Xu J, Gan L, Wang M, Sun Y, Zhang H, Wang W
Talanta 2026 Feb 1;298(Pt A):128863

---

SNX17 knockdown improves post-ischemic angiogenesis via blocking lysosomal dependent VEGFR degradation.

Tang Y, Tang S, Chen Y, Zhang J, Yu X, Mao P, Wang W, Yu J, Wang F, Zeng C
Life sciences 2025 Sep 15;377:123739

---

Multimodal spatial proteomic profiling in acute myeloid leukemia.

Ly CP, Veletic I, Pacheco CD, Dasdemir E, Jelloul FZ, Ferri-Borgogno S, Basi AV, Gomez JA, Root JL, Reville PK, Jindal S, Basu S, Sharma P, Quesada AE, Bueso-Ramos C, Manshouri T, Cuglievan B, Garcia M, Burks JK, Abbas HA
NPJ precision oncology 2025 May 20;9(1):148

---

Personalized Vascularized Tumor Organoid-on-a-Chip for Tumor Metastasis and Therapeutic Targeting Assessment.

Du Y, Wang YR, Bao QY, Xu XX, Xu C, Wang S, Liu Q, Liu F, Zeng YL, Wang YJ, Liu W, Liu Y, Yu SX, Chen YC, Wang C, Zhang W, Gao H, Luo H, Liu B, Jing G, Guo M, Chen FX, Liu YJ
Advanced materials (Deerfield Beach, Fla.) 2025 Feb;37(6):e2412815

---

Dynamics of endothelial cells migration in nature-mimicking blood vessels.

Du Y, Xu XX, Yu SX, Wang YR, Liu Y, Liu F, Liu W, Li XL, Luo H, Jing G, Liu YJ
Talanta 2024 Sep 1;277:126415

---

Design, synthesis, and biological evaluation of naphthalene imidazo[1,2-b]pyridazine hybrid derivatives as VEGFR selective inhibitors.

Wang S, Gan L, Han L, Deng P, Li Y, He D, Chi H, Zhu L, Li Y, Long R, Gan Z
Archiv der Pharmazie 2024 Oct;357(10):e2400411

---

A Nucleic Acid-Based LYTAC Plus Platform to Simultaneously Mediate Disease-Driven Protein Downregulation.

Huang Y, Zhou X, Zhang Y, Xie M, Wang F, Qin J, Ye H, Zhang H, Zhang C, Hong J
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Apr;11(13):e2306248

---

Sclareol attenuates liver fibrosis through SENP1-mediated VEGFR2 SUMOylation and inhibition of downstream STAT3 signaling.

Ge MX, Niu WX, Bao YY, Lu ZN, He HW
Phytotherapy research : PTR 2023 Sep;37(9):3898-3912

---

Exosomal B7-H3 facilitates colorectal cancer angiogenesis and metastasis through AKT1/mTOR/VEGFA pathway.

Wu R, Zhang Y, Xu X, You Q, Yu C, Wang W, Mao Y
Cellular signalling 2023 Sep;109:110737

---

PLAC8-Mediated Activation of NOX4 Signalling Restores Angiogenic Function of Endothelial Colony-Forming Cells in Experimental Hypoxia.

Pun SH, O'Neill KM, Edgar KS, Gill EK, Moez A, Naderi-Meshkin H, Malla SB, Hookham MB, Alsaggaf M, Madishetti VV, Botezatu B, King W, Brunssen C, Morawietz H, Dunne PD, Brazil DP, Medina RJ, Watson CJ, Grieve DJ
Cells 2023 Sep 6;12(18)

---

A histological study of vascular wall resident stem cells in venous malformations.

Xia HF, Lai WQ, Chen GH, Li Y, Xie QH, Jia YL, Chen G, Zhao YF
Cell and tissue research 2022 Nov;390(2):229-243

---

An Essential NRP1-Mediated Role for Tagln2 in Gastric Cancer Angiogenesis.

Jin H, Zheng W, Hou J, Peng H, Zhuo H
Frontiers in oncology 2021;11:653246

---

ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control.

Dai X, Mei Y, Chen X, Cai D
Frontiers in genetics 2019;10:790